Home Cart 0 Sign in  

[ CAS No. 564483-19-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 564483-19-8
Chemical Structure| 564483-19-8
Structure of 564483-19-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 564483-19-8 ]

Related Doc. of [ 564483-19-8 ]

Alternatived Products of [ 564483-19-8 ]

Product Details of [ 564483-19-8 ]

CAS No. :564483-19-8 MDL No. :MFCD06411306
Formula : C29H45P Boiling Point : -
Linear Structure Formula :- InChI Key :SACNIGZYDTUHKB-UHFFFAOYSA-N
M.W : 424.64 Pubchem ID :11618717
Synonyms :
Chemical Name :Di-tert-butyl(2',4',6'-triisopropyl-[1,1'-biphenyl]-2-yl)phosphine

Calculated chemistry of [ 564483-19-8 ]

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.59
Num. rotatable bonds : 7
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 142.82
TPSA : 13.59 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -2.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : 5.02
Log Po/w (XLOGP3) : 8.47
Log Po/w (WLOGP) : 9.43
Log Po/w (MLOGP) : 7.73
Log Po/w (SILICOS-IT) : 10.04
Consensus Log Po/w : 8.14

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -7.64
Solubility : 0.00000966 mg/ml ; 0.0000000228 mol/l
Class : Poorly soluble
Log S (Ali) : -8.63
Solubility : 0.000001 mg/ml ; 0.0000000024 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.81
Solubility : 0.0000000653 mg/ml ; 0.0000000002 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.8

Safety of [ 564483-19-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 564483-19-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 564483-19-8 ]
  • Downstream synthetic route of [ 564483-19-8 ]

[ 564483-19-8 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 13716-10-4 ]
  • [ 694-80-4 ]
  • [ 21524-34-5 ]
  • [ 564483-19-8 ]
YieldReaction ConditionsOperation in experiment
94%
Stage #1: With magnesium In tetrahydrofuran for 2 h; Inert atmosphere; Reflux
Stage #2: With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 5.5 h; Reflux; Inert atmosphere
1L three bottles,To a solution of 32.5 g of 2,4,6-triisopropylbromobenzene,5.6 g of magnesium turnings and 300 mL of anhydrous THF,20 g of o-chlorobromobenzene was dropwise added,2,4,6-triisopropyl-2-bromobiphenyl Grignard reagent,Refluxed for 2 hours,Down to room temperature,2.4 g of tetrakis (triphenylphosphine) palladium was added,Stirred for 30 minutes,18.8 g of di-tert-butylphosphonium chloride was added dropwise at room temperature,The reaction was refluxed for 5 hours.And the mixture was added dropwise to the reaction solution under ice-water bath200 mL of saturated aqueous ammonium chloride was quenched,Liquid separation,The organic phase is dissolved,Add methanol crystallization,And filtered to obtain 41.7 g of white 2-di-tert-butylphosphine-2,4,6-triisopropylbiphenyl,Yield 94percent.
Reference: [1] Patent: CN105859774, 2016, A, . Location in patent: Paragraph 0078; 0079; 0080; 0081
[2] Journal of the American Chemical Society, 2003, vol. 125, # 22, p. 6653 - 6655
Same Skeleton Products
Historical Records